Remove Drug Development Remove Groups Remove Life Science Remove Telemedicine
article thumbnail

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

Latest Round of Investment in the Family Engagement Technology Company Led by Bradford Whitmore and Mountain Group Partners, with Participation by SeedtoB Capital and the Rash Family Office. The Series B financing was led by Brad Whitmore and Mountain Group Partners (MGP), with participation from SeedtoB Capital and the Rash Family Office.

article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. In a recent review paper appeared on Nature , Mittermaier et al. in 2010 to 11.4%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

Henry Kotula

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

article thumbnail

Uses of AI in Healthcare – 2024 Health IT Predictions

Healthcare IT Today

We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Expansion of the use of robots in telemedicine and remote patient monitoring will enable health care providers to reach patients in underserved areas.

Health IT 105